Dr. Nora Sarvetnick. PhD
Nora Sarvetnick, Ph.D., Director of the Nebraska Regenerative Medicine Project, began her scientific career in the areas of genetics and immunology with a specific interest in diabetes. Her focus in these fields has lead her down an uncommon path of discovery, providing her a unique yet valuable background that will enable her to build a successful Regenerative Medicine Project here at UNMC. Dr. Sarvetnick became the director of the Nebraska Regenerative Medicine Project in November 2010. She was first recruited to join the surgery transplant team at UNMC as Director of Research, in the Fall of 2008. Prior to coming to UNMC, the New Jersey native had been a professor for 18 years at the Scripps Research Institute in San Diego, Calif.
Dr. Andrew Dudley. PhD
Dr. Andrew Dudley was recruited to join the Nebraska Regenerative Medicine team at the start of 2012 as an Associate Professor in the department of Genetics, Cell Biology, and Anatomy. Dr. Dudley received his PhD from Harvard University followed by a postdoctoral fellowship in the Department of Genetics where he studied skeletal function and morphogenesis. Following his training at Harvard, Dr. Dudley began his work as an Assistant Professor at Northwestern University, continuing his studies on the development of the musculoskeletal system. Currently, research in his laboratory seeks to uncover the mechanisms that regulate the development and homeostasis of musculoskeletal tissues using methods from embryology, molecular biology, cell biology, genetics, and tissue engineering, with the goal of generating novel therapies for regenerative medicine.
Dr. Brian Boerner. MD
Dr. Brian Boerner, an Assistant Professor in the department of Internal Medicine with a specialty in diabetes, endocrine, and metabolism. Dr. Boerner received his medical degree at The University of Nebraska Medical Center and completed his residency and fellowship here as well. Dr. Boerner's research is focused on human pancreatic beta cell regeneration and improving outcomes for those who develop diabetes or other endocrinological disorders following transplant.
Dr. James Hammel
Dr. James Hammel earned his medical degree from the University of Michigan Medical School followed by the completion of several surgical residencies and fellowships in the areas of Thoracic, General, and Congenital and Neonatal Cardiac, and Transplant surgery prior to joining the team at UNMC. Dr. Hammel is an Assistant Professor in the Department of Surgery, Cardiothoracic at UNMC and Chief of Pediatric Cardiac Surgery at Children's Hospital. Dr. Hamme's reserach interests focus on the creation of a cell based matrix that is would serve to replace a defective heart valve. By testing various cell types, he hopes to determine which environments are best suited to grow, form, and generate functional tissue valves.